HC Wainwright Has Bearish Estimate for Senestech Q2 Earnings

Senestech, Inc. (NASDAQ:SNES) – Investment analysts at HC Wainwright lowered their Q2 2026 earnings estimates for Senestech in a research note issued on Friday, May 15th. HC Wainwright analyst A. Dayal now anticipates that the company will post earnings per share of ($0.40) for the quarter, down from their prior estimate of ($0.34). The consensus estimate for Senestech’s current full-year earnings is ($1.36) per share. HC Wainwright also issued estimates for Senestech’s Q3 2026 earnings at ($0.41) EPS, Q4 2026 earnings at ($0.41) EPS, FY2026 earnings at ($1.61) EPS, FY2027 earnings at ($1.43) EPS, FY2028 earnings at ($0.67) EPS and FY2029 earnings at $0.10 EPS.

Senestech (NASDAQ:SNES) last announced its quarterly earnings data on Tuesday, May 12th. The company reported ($0.31) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.02. Senestech had a negative net margin of 304.22% and a negative return on equity of 67.60%. The company had revenue of $0.49 million during the quarter, compared to the consensus estimate of $0.63 million.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research report on Friday, March 27th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Senestech presently has an average rating of “Hold”.

Senestech Stock Performance

Shares of SNES opened at $1.59 on Tuesday. Senestech has a one year low of $1.41 and a one year high of $6.24. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.91 and a quick ratio of 7.79. The firm has a 50-day moving average of $1.70 and a 200-day moving average of $2.16. The company has a market cap of $8.43 million, a PE ratio of -0.84 and a beta of 0.18.

Institutional Investors Weigh In On Senestech

A number of institutional investors have recently added to or reduced their stakes in SNES. Sabby Management LLC grew its holdings in Senestech by 195.4% during the 4th quarter. Sabby Management LLC now owns 210,564 shares of the company’s stock worth $451,000 after acquiring an additional 139,281 shares during the last quarter. DRW Securities LLC grew its holdings in Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after acquiring an additional 51,818 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after acquiring an additional 37,165 shares during the last quarter. Jane Street Group LLC bought a new stake in Senestech during the 2nd quarter worth approximately $161,000. Finally, Millennium Management LLC bought a new stake in Senestech during the 3rd quarter worth approximately $126,000. 5.19% of the stock is owned by institutional investors.

Insider Transactions at Senestech

In other Senestech news, major shareholder Glenbrook Capital Management bought 146,249 shares of Senestech stock in a transaction on Friday, March 13th. The shares were purchased at an average cost of $1.95 per share, with a total value of $285,185.55. Following the acquisition, the insider directly owned 865,850 shares of the company’s stock, valued at $1,688,407.50. The trade was a 20.32% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last ninety days, insiders have purchased 254,248 shares of company stock worth $499,846. 2.20% of the stock is owned by corporate insiders.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.